MEL 80 EXCIMER LASER SYSTEM

FDA Premarket Approval P060004

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the mel 80 excimer laser system. The device uses an optical zone of 6. 0 to 7. 0 mm in diameter and a transition zone of 1. 7 to 1. 9 mm for total ablation diameter of 7. 7 to 8. 9 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of myopia of less than or equal to -7. 0 d, with or without refractive astigmatism of less than or equal to -3. 0 d, with a maximum mrse of -7. 00 d; 2) in patients who are 21 years of age or older; 3) with documentation of stable manifest refraction over the past year as demonstrated by change in sphere and cylinder of

DeviceMEL 80 EXCIMER LASER SYSTEM
Generic NameExcimer Laser System
ApplicantCarl Zeiss Meditec, Inc.
Date Received2006-02-14
Decision Date2006-08-11
Notice Date2006-08-25
PMAP060004
SupplementS
Product CodeLZS 
Docket Number06M-0342
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Carl Zeiss Meditec, Inc. 5160 Hacienda Drive dublin, CA 94568
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P060004Original Filing
S002 2008-01-18 30-day Notice
S001 2007-12-28 Panel Track

NIH GUDID Devices

Device IDPMASupp
04049471000221 P060004 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.